1579 Results

People

  1. Cheung
    Cheung
  2. Wolchok
    Wolchok
  3. Postow
    Postow
  4. Hellmann
    Hellmann
  5. Adusumilli
    Adusumilli
  6. Old
    Old
  7. Livingston
    Livingston
  8. Motzer
    Motzer
  9. Slovin
    Slovin
  10. Houghton
    Houghton

Groups

  1. Department of Medicine (882)
  2. Solid Tumor Oncology Division (646)
  3. GSK Faculty (409)
  4. Hematologic Malignancies, Division of (373)
  5. Sloan Kettering Institute Postdocs (252)
  6. Melanoma and Immunotherapeutics Service (227)
  7. Center for Hematologic Malignancies (221)
  8. Surgery (221)
  9. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (191)
  10. Melanoma Disease Management Team (186)
  1. "immunotherapy"
Formats
  1. Journal Article (1126)
  2. Review (243)
  3. Editorial (60)
  4. Meeting Abstract (57)
  5. Book Section (30)
  6. Guidelines (28)
  7. Research Letter (14)
  8. Conference Paper (9)
  9. Correspondence (7)
  10. Miscellaneous (5)
Groups
  1. Department of Medicine (882)
  2. Solid Tumor Oncology Division (646)
  3. GSK Faculty (409)
  4. Hematologic Malignancies, Division of (373)
  5. Sloan Kettering Institute Postdocs (252)
  6. Melanoma and Immunotherapeutics Service (227)

More Groups

People
  1. Jedd Wolchok (107)
  2. Nai-Kong Cheung (71)
  3. Michael Postow (67)
  4. Matthew Hellmann (53)
  5. Prasad Adusumilli (39)
  6. Michel Sadelain (36)

More People

Years
  1. 2025 (69)
  2. 2024 (160)
  3. 2023 (135)
  4. 2022 (134)
  5. 2021 (129)
  6. 2020 (102)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (117)
  2. Journal of Thoracic Oncology (55)
  3. Clinical Cancer Research (41)
  4. Annals of Oncology (35)
  5. Cancer Immunology, Immunotherapy (29)
  6. Cancer (28)

More Publications

Publishers
  1. Elsevier Inc. (242)
  2. Biomed Central Ltd (139)
  3. Springer (103)
  4. Wiley Blackwell (83)
  5. American Association for Cancer Research (69)
  6. Oxford University Press (67)

More Publishers

Results (1579)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The role of radiation, immunotherapy, and chemotherapy in the management of locally advanced or metastatic cutaneous malignancies
    Review

    Yacoub, I.; Rayn, K.; Choi, J. I.; Bakst, R.; Chhabra, A.; Qian, J. Y.; Johnstone, P.; Simone, C. B. 2nd
    Cancers (2024)

    Fulltext@MSK | Save
  • Lung cancer research and treatment: Global perspectives and strategic calls to action
    Review

    Meyer, M. L.; Peters, S.; Mok, T. S.; Lam, S.; Yang, P. C.; Aggarwal, C.; Brahmer, J.; Dziadziuszko, R.; Felip, E.; Ferris, A.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Durable complete response in a patient with leptomeningeal melanoma after treatment with dabrafenib, trametinib, and nivolumab
    Journal Article

    Lochrin, S. E.; Buonocore, D. J.; Young, R. J.; Kaley, T. J.; Postow, M. A.; Wolchok, J. D.; Shoushtari, A. N.; Momtaz, P.; Betof Warner, A. S.; Callahan, M. K.
    Pigment Cell & Melanoma Research (2024)

    Fulltext@MSK | Save
  • Neoantigen immunogenicity landscapes and evolution of tumor ecosystems during immunotherapy with nivolumab
    Journal Article

    Alban, T. J.; Riaz, N.; Parthasarathy, P.; Makarov, V.; Kendall, S.; Yoo, S. K.; Shah, R.; Weinhold, N.; Srivastava, R.; Ma, X.; more...
    Nature Medicine (2024)

    Fulltext@MSK | Save
  • CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors
    Journal Article

    Skoulidis, F.; Araujo, H. A.; Do, M. T.; Qian, Y.; Sun, X.; Cobo, A. G.; Le, J. T.; Montesion, M.; Palmer, R.; Jahchan, N.; more...
    Nature (2024)

    Fulltext@MSK | Save
  • Appropriate Use Criteria (AUC) for the management of non-small cell lung cancer in a central/ultra-central location: Guidelines from the American Radium Society
    Guidelines

    Park, H. S.; Rimner, A.; Amini, A.; Chang, J. Y.; Chun, S. G.; Donington, J.; Edelman, M. J.; Gubens, M. A.; Higgins, K. A.; Iyengar, P.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • NCCN Guidelines® Insights: Management of Immunotherapy-Related Toxicities, version 2.2024: Featured updates to the NCCN Guidelines
    Guidelines

    Thompson, J. A.; Schneider, B. J.; Brahmer, J.; Zaid, M. A.; Achufusi, A.; Armand, P.; Berkenstock, M. K.; Bermas, B.; Braaten, T.; Budde, L. E.; more...
    Journal of the National Comprehensive Cancer Network (2024)

    Fulltext@MSK | Save
  • Clinical benefit with tebentafusp in a patient with GNAQ mutant metastatic blue nevus-associated melanoma
    Journal Article

    Kudelka, M. R.; Richards, A. L.; Friedlander, P.; Wolchok, J. D.; Moy, A. P.; Shoushtari, A. N.
    Journal for ImmunoTherapy of Cancer (2024)

    Fulltext@MSK | Save
  • Diversity of the immune microenvironment and response to checkpoint inhibitor immunotherapy in mucosal melanoma
    Journal Article

    Vos, J. L.; Traets, J. J. H.; Qiao, X.; Seignette, I. M.; Peters, D.; Wouters, M. W. J. M.; Hooijberg, E.; Broeks, A.; van der Wal, J. E.; Baris Karakullukcu, M.; more...
    JCI Insight (2024)

    Fulltext@MSK | Save
  • T cells standing at the gates of brain metastasis
    Editorial

    Remsik, J.; Boire, A.
    Immunity (2024)

    Fulltext@MSK | Save